PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2018
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2018
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro.
Brigante G, Riccetti L, Lazzaretti C, Rofrano L, Sperduti S, Potì F, Diazzi C, Prodam F, Guaraldi G, Lania AG, Rochira V, Casarini L.
Mol Cell Endocrinol. 2018 Dec 11. pii: S0303-7207(18)30358-7. doi: 10.1016/j.mce.2018.12.005.
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014.
d'Arminio Monforte A, Diaz-Cuervo H, De Luca A, Maggiolo F, Cingolani A, Bonora S, Castagna A, Girardi E, Antinori A, Lo Caputo S, Guaraldi G, Cozzi-Lepri A; ICONA Foundation Study Group.
HIV Med. 2019 Feb;20(2):99-109. doi: 10.1111/hiv.12683. Epub 2018 Nov 21.
Managing antiretroviral therapy in the elderly HIV patient.
Guaraldi G, Pintassilgo I, Milic J, Mussini C.
Expert Rev Clin Pharmacol. 2018 Nov 16:1-11. doi: 10.1080/17512433.2018.1549484. [Epub ahead of print]
Construct validation of a Frailty Index, an HIV Index and a Protective Index from a clinical HIV database.
Franconi I, Theou O, Wallace L, Malagoli A, Mussini C, Rockwood K, Guaraldi G.
PLoS One. 2018 Oct 17;13(10):e0201394. doi: 10.1371/journal.pone.0201394. eCollection 2018.
Chronic Lung Disease in HIV Patients
Neri S, Leung J, Besutti G, Santoro A, Fabbri LM, Guaraldi G.
AIDS Rev. 2018;20(3):150-157. doi: 10.24875/AIDSRev.18000002.
Immunophenotypic profile and clinical outcome of monoclonal B-cell lymphocytosis in kidney transplantation.
Alfano G, Fontana F, Colaci E, Franceschini E, Ligabue G, Messerotti A, Bettelli F, Grottola A, Gennari W, Potenza L, Guaraldi G, Mussini C, Luppi M, Cappelli G.
Clin Transplant. 2018 Aug;32(8):e13338. doi: 10.1111/ctr.13338. Epub 2018 Aug 26.
A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice.
Di Biagio A, Riccardi N, Rusconi S, Guaraldi G, Borderi M, De Luca A, Gianotti N, Lo Caputo S, Maggi P, Maserati R, Maggiolo F.
AIDS Rev. 2018 Apr-Jun;20(2):75-82.
Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ≥50 years: Final 96 Weeks Results of NEAT 022 study.
Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Stephan C, Rockstroh J, Giacomelli A, Vera J, Bernardino JI, Winston A, Saumoy M, Gras J, Katlama C, Pozniak AL; NEAT022 Study Group.
Clin Infect Dis. 2018 Jun 14. doi: 10.1093/cid/ciy505.
Pre-exposure Prophylaxis for HIV Infection in the Older Patient: What can be Recommended?
Franconi I, Guaraldi G.
Drugs Aging. 2018 May 8. doi: 10.1007/s40266-018-0553-3. [Epub ahead of print]
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
Guaraldi G, Malagoli A, Calcagno A, Mussi C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G, Riva A, Focà E, Nozza S, Di Perri G.
BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics.
De Francesco D, Wit FW, Cole JH, Kootstra NA, Winston A, Sabin CA, Underwood J, van Zoest RA, Schouten J, Kooij KW, Prins M, Guaraldi G, Caan MWA, Burger D, Franceschi C, Libert C, Bürkle A, Reiss P; COmorBidity in Relation to AIDS (COBRA) collaboration.
PLoS One. 2018 Mar 29;13(3):e0191791. doi: 10.1371/journal.pone.0191791. eCollection 2018.
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature.
Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G, Ballarin R, Rossi G, Franceschini E, Codeluppi M, Guaraldi G, Mussini C, Di Benedetto F, Cappelli G.
Transplant Proc. 2018 Apr;50(3):905-909. doi: 10.1016/j.transproceed.2017.11.036. Epub 2018 Mar 22. Review.
Treatment rate for HCV in the direct-acting antivirals era in HIV co-infected patients: data from an Italian cohort.
Cuomo G, Puzzolante C, Lazzaretti C, Guaraldi G, Borghi V, Mussini C.
Minerva Med. 2018 Jun;109(3):203-210. doi: 10.23736/S0026-4806.18.05435-6. Epub 2018 Jan 31.
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.
Lionetti R, Calvaruso V, Piccolo P, Mancusi RL, Mazzarelli C, Fagiuoli S, Montalbano M, Lenci I, Carrai P, Guaraldi G, Visco-Comandini U, Milana M, Biolato M, Loiacono L, Valente G, Craxì A, Angelico M, D'offizi G.
Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13165. Epub 2017 Dec 18.
Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.
Erlandson KM, Lake JE, Sim M, Falutz J, Prado CM, Domingues da Silva AR, Brown TT, Guaraldi G.
J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):288-294. doi: 10.1097/QAI.0000000000001591.
Role of tenofovir alafenamide in the jungle of antiretroviral prescription.
Guaraldi G. J Antimicrob Chemother.
2018 Jan 1;73(1):264. doi: 10.1093/jac/dkx416. No abstract available.
Role of tenofovir alafenamide in the jungle of antiretroviral prescription.
Guaraldi G. J Antimicrob Chemother.
2018 Jan 1;73(1):261-262. doi: 10.1093/jac/dkx346. No abstract available.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena